KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Workhorse (WKHS) Cash & Equivalents (2016 - 2025)

Workhorse has reported Cash & Equivalents over the past 16 years, most recently at $12.9 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 94.9% to $12.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.9 million through Dec 2025, up 94.9% year-over-year, with the annual reading at $12.9 million for FY2025, 94.9% up from the prior year.
  • Cash & Equivalents was $12.9 million for Q4 2025 at Workhorse, up from $12.7 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $230.4 million in Q3 2021 and troughed at $2.2 million in Q2 2025.
  • The 5-year median for Cash & Equivalents is $50.6 million (2023), against an average of $78.9 million.
  • Year-over-year, Cash & Equivalents soared 1118.9% in 2021 and then tumbled 91.66% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $201.6 million in 2021, then crashed by 50.77% to $99.3 million in 2022, then plummeted by 73.97% to $25.8 million in 2023, then plummeted by 74.35% to $6.6 million in 2024, then surged by 94.9% to $12.9 million in 2025.
  • Per Business Quant, the three most recent readings for WKHS's Cash & Equivalents are $12.9 million (Q4 2025), $12.7 million (Q3 2025), and $2.2 million (Q2 2025).